Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles

Area of Science:

• Immunology
• Biotechnology
• Nanomedicine

Background:

• Phagocytes clear foreign particles but must distinguish them from "self" cells.
• The CD47 protein acts as a "self" marker in mice, inhibiting phagocytosis via the CD172a receptor.
• Understanding CD47-CD172a interactions is crucial for controlling immune clearance.

Purpose of the Study:

• To design and synthesize minimal "Self" peptides from human CD47.
• To investigate the effect of these peptides on nanoparticle clearance by macrophages.
• To evaluate the potential of "Self" peptides in enhancing drug and dye delivery.

Main Methods:

• Computational design of minimal "Self" peptides based on human CD47.
• Synthesis of peptides and their attachment to virus-size nanoparticles.
• Intravenous injection of peptide-conjugated nanoparticles into mice expressing a compatible CD172a variant.
• Assessment of nanoparticle circulation time and macrophage-mediated clearance.
• Evaluation of nanoparticle uptake inhibition and drug delivery efficacy.

Main Results:

• "Self" peptides significantly delayed macrophage-mediated clearance of nanoparticles.
• Enhanced nanoparticle circulation promoted improved dye and drug delivery to tumors.
• The designed "Self" peptides demonstrated high affinity for CD172a.
• Peptide conjugation potently inhibited nanoparticle uptake via the contractile cytoskeleton.

Conclusions:

• Minimal human "Self" peptides can effectively shield nanoparticles from phagocytosis.
• This approach enhances nanoparticle persistence, improving therapeutic and imaging agent delivery.
• The reductionist strategy highlights the significance of "Self" peptides in nanomedicine applications.